Cited by 3,027Parkinson's Disease Mechanisms and TreatmentsDementia and Cognitive Impairment ResearchDeep Brain Stimulation and Movement Disorders

The DOI matches its Crossref record; 188 of the 188 references it cites were found in a registry or an index.

Clinical diagnostic criteria for dementia associated with Parkinson’s disease

Open access

Emre, Murat, Aarsland, Dag, Brown, Richard, Burn, David J., Duyckaerts, Charles, Mizuno, Yoshikino, Broe, Gerald Anthony, Cummings, Jeffrey, Dickson, Dennis W., Gauthier, Serge, Goldman, Jennifer, Goetz, Christopher, Korczyn, Amos, Lees, Andrew, Levy, Richard, Litvan, Irene, McKeith, Ian, Olanow, Warren, Poewe, Werner, Quinn, Niall, Sampaio, Christina, Tolosa, Eduardo, Dubois, Bruno·2007·Movement Disorders

DOI 10.1002/mds.21507

Open this paper in CoChat — free account

Abstract

Dementia has been increasingly more recognized to be a common feature in patients with Parkinson's disease (PD), especially in old age. Specific criteria for the clinical diagnosis of dementia associated with PD (PD‐D), however, have been lacking. A Task Force, organized by the Movement Disorder Study, was charged with the development of clinical diagnostic criteria for PD‐D. The Task Force members were assigned to sub‐committees and performed a systematic review of the literature, based on pre‐defined selection criteria, in order to identify the epidemiological, clinical, auxillary, and pathological features of PD‐D. Clinical diagnostic criteria were then developed based on these findings and group consensus. The incidence of dementia in PD is increased up to six times, point‐prevelance is close to 30%, older age and akinetic‐rigid form are associated with higher risk. PD‐D is characterized by impairment in attention, memory, executive and visuo‐spatial functions, behavioral symptoms such as affective changes, hallucinations, and apathy are frequent. There are no specific ancillary investigations for the diagnosis; the main pathological correlate is Lewy body‐type degeneration in cerebral cortex and limbic structures. Based on the characteristic features associated with this condition, clinical diagnostic criteria for probable and possible PD‐D are proposed. © 2007 Movement Disorder Society

Integrity signals

Registry

Crossref · 10.1002/mds.21507

Cites

188 of 188 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Mutation in the α-Synuclein Gene Identified in Families with Parkinson's Disease
Polymeropoulos, M. H., Lavedan, C., Leroy, E., Ide, S. E., Dehejia, A., Dutra, A., Pike, B., Root, H., Rubenstein, J., Boyer, R., et al. (1997) · Science · doi:10.1126/science.276.5321.2045 · Cited by 8,240
The Neuropsychiatric Inventory: Comprehensive assessment of psychopathology in dementia
Cummings, J. L., Mega, M., Gray, K., Rosenberg-Thompson, S., Carusi, D. A., & Gornbein, J. (1994) · Neurology · doi:10.1212/wnl.44.12.2308 · Cited by 7,568
Self-citation
Diagnosis and management of dementia with Lewy bodies: Third report of the DLB consortium
McKeith, I. G., Dickson, D. W., Lowe, J., Emre, M., O'Brien, J. T., Feldman, H., Cummings, J., Duda, J. E., Lippa, C., Perry, E. K., et al. (2005) · Neurology · doi:10.1212/01.wnl.0000187889.17253.b1 · Cited by 5,069
Self-citation
α-Synuclein Locus Triplication Causes Parkinson's Disease
Singleton, A. B., Farrer, M., Johnson, J., Singleton, A., Hague, S., Kachergus, J., Hulihan, M., Peuralinna, T., Dutra, A., Nussbaum, R., et al. (2003) · Science · doi:10.1126/science.1090278 · Cited by 4,383
The new mutation, E46K, of α‐synuclein causes parkinson and Lewy body dementia
Zarranz, J. J., Alegre, J., Gómez‐Esteban, J. C., Lezcano, E., Ros, R., Ampuero, I., Vidal, L., Hoenicka, J., Rodriguez, O., Atarés, B., et al. (2004) · Annals of Neurology · doi:10.1002/ana.10795 · Cited by 2,737
A systematic review of prevalence studies of dementia in Parkinson's disease
Aarsland, D., ZACCAI, J. H., & Brayne, C. (2005) · Movement Disorders · doi:10.1002/mds.20527 · Cited by 1,714
Self-citation
Prevalence and Characteristics of Dementia in Parkinson Disease
Aarsland, D., Andersen, K., Larsen, J. O., & Lolk, A. (2003) · Archives of Neurology · doi:10.1001/archneur.60.3.387 · Cited by 1,403
Self-citation
Rivastigmine for Dementia Associated with Parkinson's Disease
Emre, M., Aarsland, D., Albanese, A., Byrne, E. J., Deuschl, G., Deyn, P. P. D., Durif, F., Kulisevsky, J., van Laar, T., Lees, A. J., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa041470 · Cited by 1,219
Self-citation
Sydney multicenter study of Parkinson's disease: Non‐L‐dopa–responsive problems dominate at 15 years
Hely, M. A., Morris, J. G. L., Reid, W. G. J., & Trafficante, R. (2005) · Movement Disorders · doi:10.1002/mds.20324 · Cited by 1,050
Hallucinations in Parkinson's disease: Prevalence, phenomenology and risk factors
Fénelon, G. (2000) · Brain · doi:10.1093/brain/123.4.733 · Cited by 1,035

Show all 187 references

Research works printed but not linked: 3

McKeith IG, 2000, Neurologic clinics, 865
10.1136/jnnp.2003.033530 · DOI
10.1002/1099-1166(200102)16:2<184::AID-GPS304>3.0.CO;2-K · DOI

Sorted by citations

Items 501–600 of 1,006

Impairments of speech fluency in Lewy body spectrum disorder
Ash, S., McMillan, C. T., Gross, R. G., Cook, P. A., Gunawardena, D., Morgan, B. E., Boller, A., Siderowf, A. D., & Grossman, M. (2011) · Brain and Language · doi:10.1016/j.bandl.2011.09.004 · Cited by 75
Neural correlates of attention‐executive dysfunction in lewy body dementia and Alzheimer's disease
Firbank, M., Kobeleva, X., Cherry, G., Killen, A., Gallagher, P., Burn, D. J., Thomas, A. J., O'Brien, J. T., & Taylor, J. (2015) · Human Brain Mapping · doi:10.1002/hbm.23100 · Cited by 69
Self-citation
Meta-analysis of risk factors for Parkinson’s disease dementia
Xu, Y., Yang, J., & Shang, H. (2016) · Translational Neurodegeneration · doi:10.1186/s40035-016-0058-0 · Cited by 70
Can neuroimaging predict dementia in Parkinson’s disease?
Lanskey, J. H., McColgan, P., Schrag, A. E., Acosta‐Cabronero, J., Rees, G. E., Morris, H. R., & Weil, R. S. (2018) · Brain · doi:10.1093/brain/awy211 · Cited by 76
Distinct patterns of amyloid‐dependent tau accumulation in Lewy body diseases
Lee, S. H., Cho, H., Choi, J. Y., Lee, J., Ryu, Y. H., Lee, M. S., & Lyoo, C. H. (2017) · Movement Disorders · doi:10.1002/mds.27252 · Cited by 71
Polymorphism of the dopamine transporter type 1 gene modifies the treatment response in Parkinson’s disease
Moreau, C., Meguig, S., Corvol, J., Labreuche, J., Vasseur, F., Duhamel, A., Delval, A., Bardyn, T., Devedjian, J.-C., Rouaix, N., et al. (2015) · Brain · doi:10.1093/brain/awv063 · Cited by 69
Intra‐ and inter‐network functional alterations in P arkinson's disease with mild cognitive impairment
Peraza, L. R., Nesbitt, D. J., Lawson, R. A., Duncan, G. W., Yarnall, A. J., Khoo, T. K., Kaiser, M., Firbank, M., O'Brien, J. T., Barker, R. A., et al. (2017) · Human Brain Mapping · doi:10.1002/hbm.23499 · Cited by 71
Self-citation
Electroencephalographic derived network differences in Lewy body dementia compared to Alzheimer’s disease patients
Peraza, L. R., Cromarty, R. A., Kobeleva, X., Firbank, M., Killen, A., Graziadio, S., Thomas, A. J., O'Brien, J. T., & Taylor, J. (2018) · Scientific Reports · doi:10.1038/s41598-018-22984-5 · Cited by 68
Plasma Biomarkers Differentiate Parkinson’s Disease From Atypical Parkinsonism Syndromes
Lin, C., Yang, S.-Y., Horng, H. E., Yang, C., Chieh, J.-J., Chen, H.-H., Liu, B.-H., & Chiu, M. (2018) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2018.00123 · Cited by 69
Lysosomal cathepsin D is upregulated in Alzheimer's disease neocortex and may be a marker for neurofibrillary degeneration
Chai, Y. L., Chong, J. R., Weng, J., Howlett, D., Halsey, A., Lee, J. H., Attems, J., Aarsland, D., Francis, P. T., Chen, C. P., et al. (2019) · Brain Pathology · doi:10.1111/bpa.12631 · Cited by 73
Self-citation
Pathophysiology of non-motor signs in Parkinson’s disease: some recent updating with brief presentation
Radad, K., Moldzio, R., Krewenka, C., Kranner, B., & Rausch, W. (2023) · Exploration of Neuroprotective Therapy · doi:10.37349/ent.2023.00036 · Cited by 68
Redefining Non-Motor Symptoms in Parkinson’s Disease
Peña-Zelayeta, L., Delgado-Minjares, K. M., Villegas-Rojas, M. M., León‐Arcia, K., Santiago-Balmaseda, A., Andrade-Guerrero, J., Pérez-Segura, I., Ortega‐Robles, E., Soto-Rojas, L. O., & Arias-Carrión, Ó. (2025) · Journal of Personalized Medicine · doi:10.3390/jpm15050172 · Cited by 80
Cognitive impairment and dementia in patients with Parkinson disease.
Leverenz, J. B., Quinn, J. F., Zabetian, C. P., Zhang, J., Montine, K. S., & Montine, T. J. (2009) · PubMed · Cited by 69
Parkinson disease: Insights in clinical, genetic and pathological features of monogenic disease subtypes
Crosiers, D., Theuns, J., Cras, P. P., & Broeckhoven, C. V. (2011) · Journal of Chemical Neuroanatomy · doi:10.1016/j.jchemneu.2011.07.003 · Cited by 70
The cognitive profile and CSF biomarkers in dementia with Lewy bodies and Parkinson's disease dementia
Andersson, M., Zetterberg, H., Minthon, L., Blennow, K., & Londos, E. (2011) · International Journal of Geriatric Psychiatry · doi:10.1002/gps.2496 · Cited by 71
The pattern of attentional deficits in Parkinson's disease
Dujardin, K., Tard, C., Duhamel, A., Delval, A., Moreau, C., Devos, D., & Defebvre, L. (2012) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2012.11.001 · Cited by 68
Modeling freezing of gait in Parkinson's disease with a virtual reality paradigm
Shine, J. M., Matar, E., Bolitho, S., Dilda, V., Morris, T. R., Naismith, S. L., Moore, S. T., & Lewis, S. J. G. (2012) · Gait & Posture · doi:10.1016/j.gaitpost.2012.10.026 · Cited by 68
Mild cognitive impairment in Parkinson’s disease: Diagnosis and progression to dementia
Hernández, I. G., Nieto, A., Lorenzo, J. N., & Barroso, J. (2015) · Journal of Clinical and Experimental Neuropsychology · doi:10.1080/13803395.2015.1087465 · Cited by 68
Cognitive impairment in Parkinson's disease: impact on quality of life of carers
Lawson, R. A., Yarnall, A. J., Johnston, F., Duncan, G. W., Khoo, T. K., Collerton, D., Taylor, J., Burn, D. J., & On behalf of the ICICLE‐PD study group (2016) · International Journal of Geriatric Psychiatry · doi:10.1002/gps.4623 · Cited by 68
Self-citation
Prodromal Dementia with Lewy Bodies and Prodromal Alzheimer’s Disease: A Comparison of the Cognitive and Clinical Profiles
Sadiq, D., Whitfield, T. J., Lee, L., Stevens, T., Costafreda, S. G., & Walker, Z. (2017) · Journal of Alzheimer s Disease · doi:10.3233/jad-161089 · Cited by 72
Assessment and Management of Neuropsychiatric Symptoms in Parkinson’s Disease
Mueller, C., Rajkumar, A. P., Wan, Y.-M., Velayudhan, L., Ffytche, D. H., Chaudhuri, К. R., & Aarsland, D. (2018) · CNS Drugs · doi:10.1007/s40263-018-0540-6 · Cited by 78
Self-citation
Mild behavioral impairment is linked to worse cognition and brain atrophy in Parkinson disease
Yoon, E. J., Ismail, Z., Hanganu, A., Kibreab, M., Hammer, T., Cheetham, J., Kathol, I., Sarna, J. R., Martino, D., Furtado, S., et al. (2019) · Neurology · doi:10.1212/wnl.0000000000007968 · Cited by 68
Advances in Management of Neuropsychiatric Syndromes in Neurodegenerative Diseases
Cummings, J. L., Ritter, A. R., & Rothenberg, K. G. (2019) · Current Psychiatry Reports · doi:10.1007/s11920-019-1058-4 · Cited by 72
Self-citation
Epidemiology of early onset dementia and its clinical presentations in the province of Modena, Italy
Chiari, A., Vinceti, G., Adani, G., Tondelli, M., Galli, C., Fiondella, L., Costa, M., Molinari, M. A., Filippini, T., Zamboni, G., et al. (2020) · Alzheimer s & Dementia · doi:10.1002/alz.12177 · Cited by 72
The management of dementia worldwide: A review on policy practices, clinical guidelines, end-of-life care, and challenge along with aging population
Wang, C., Song, P., & Niu, Y. (2022) · BioScience Trends · doi:10.5582/bst.2022.01042 · Cited by 67
Parkinson disease-associated cognitive impairment
(2021) · Nature Reviews Disease Primers · doi:10.1038/s41572-021-00286-x · Cited by 73
Corticolimbic gray matter loss in Parkinson’s disease without dementia
Nishio, Y., Hirayama, K., Takeda, A., Hosokai, Y., Ishioka, T., Suzuki, K., Itoyama, Y., Takahashi, S., & Mori, E. (2010) · European Journal of Neurology · doi:10.1111/j.1468-1331.2010.02980.x · Cited by 67
Wavelet Energy and Wavelet Coherence as EEG Biomarkers for the Diagnosis of Parkinson’s Disease-Related Dementia and Alzheimer’s Disease
Jeong, D., Kim, Y., Song, I., Chung, Y., & Jeong, J. (2015) · Entropy · doi:10.3390/e18010008 · Cited by 66
Diffusion Tensor Imaging Reveals White Matter Changes Associated With Cognitive Status in Patients With Parkinson’s Disease
Deng, B., Zhang, Y., Wang, L., Peng, K., Han, L., Nie, K., Yang, H., Zhang, L., & Wang, J. (2012) · American Journal of Alzheimer s Disease & Other Dementias® · doi:10.1177/1533317512470207 · Cited by 66
Normal ‘heart’ in Parkinson's disease: is this a distinct clinical phenotype?
Kim, J., Park, H. ‐., Park, I. ‐., Oh, Y., Ryu, D.-W., Song, I., Jung, Y. ‐., Yoo, I. R., Choi, H. ‐., Lee, P. H., et al. (2016) · European Journal of Neurology · doi:10.1111/ene.13206 · Cited by 71
Intrinsic brain connectivity predicts impulse control disorders in patients with Parkinson's disease
Tessitore, A., Micco, R. D., Giordano, A., Nardo, F. D., Caiazzo, G., Siciliano, M., Stefano, M. D., Russo, A., Esposito, F., & Tedeschi, G. (2017) · Movement Disorders · doi:10.1002/mds.27139 · Cited by 66
Single-subject SPM FDG-PET patterns predict risk of dementia progression in Parkinson disease
Pilotto, A., Premi, E., Caminiti, S. P., Presotto, L., Turrone, R., Alberici, A., Paghera, B., Borroni, B., Padovani, A., & Perani, D. (2018) · Neurology · doi:10.1212/wnl.0000000000005161 · Cited by 67
Relationship between apathy and cognitive dysfunctions in de novo untreated P arkinson's disease: a prospective longitudinal study
Santangelo, G., Vitale, C., Trojano, L., Picillo, M., Moccia, M., Pisano, G., Pezzella, D., Cuoco, S., Erro, R., Longo, K., et al. (2014) · European Journal of Neurology · doi:10.1111/ene.12467 · Cited by 70
Gray matter correlations of cognition in incident Parkinson's disease
Dalaker, T. O., Zivadinov, R., Larsen, J. O., Beyer, M. K., Cox, J. L., Alves, G. W., Brønnick, K., Tysnes, O., Antulov, R., Dwyer, M. G., et al. (2010) · Movement Disorders · doi:10.1002/mds.22867 · Cited by 66
Self-citation
A Scoping Review of Cognitive Training in Neurodegenerative Diseases via Computerized and Virtual Reality Tools: What We Know So Far
Lasaponara, S., Marson, F., Doricchi, F., & Cavallo, M. (2021) · Brain Sciences · doi:10.3390/brainsci11050528 · Cited by 72
Association between choroid plexus volume and cognition in Parkinson disease
Jeong, S. H., Jeong, H., Sunwoo, M. K., Ahn, S. S., Lee, S., Lee, P. H., Kim, Y. J., Sohn, Y. H., Park, C. J., & Chung, S. J. (2023) · European Journal of Neurology · doi:10.1111/ene.15999 · Cited by 66
Diagnosis and treatment of dementia in neurology outpatient departments of general hospitals in China
Jia, J., Zuo, X., Jia, X., Chu, C., Wu, L., Zhou, A., Wei, C., Tang, Y., Li, D., Qin, W., et al. (2015) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2015.06.1892 · Cited by 66
The tools of the trade: A state of the art “How to Assess Cognition” in the patient with Parkinson's disease
Marras, C., Tröster, A. I., Kulisevsky, J., & Stebbins, G. T. (2014) · Movement Disorders · doi:10.1002/mds.25874 · Cited by 66
The spectrum of cognitive disorders in P arkinson's disease: A data‐driven approach
Dujardin, K., Leentjens, A. F. G., Langlois, C., Moonen, A. J. H., Duits, A., Carette, A., & Duhamel, A. (2013) · Movement Disorders · doi:10.1002/mds.25311 · Cited by 66
Short latency afferent inhibition in Parkinson's disease patients with dementia
Çelebi, Ö. Ö., Temuçin, Ç. M., Elibol, B., & Saka, E. (2012) · Movement Disorders · doi:10.1002/mds.25040 · Cited by 66
Impaired financial abilities in Parkinson's disease patients with mild cognitive impairment and dementia
Martin, R. C., Triebel, K. L., Kennedy, R., Nicholas, A. P., Watts, R. L., Stover, N. P., Brandon, M. D., & Marson, D. C. (2013) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2013.06.017 · Cited by 66
Abnormal daytime sleepiness in dementia with Lewy bodies compared to Alzheimer’s disease using the Multiple Sleep Latency Test
Ferman, T. J., Smith, G. E., Dickson, D. W., Graff‐Radford, N. R., Lin, S.-C., Wszołek, Z. K., van Gerpen, J. A., Uitti, R. J., Knopman, D. S., Petersen, R. C., et al. (2014) · Alzheimer s Research & Therapy · doi:10.1186/s13195-014-0076-z · Cited by 68
Self-citation
Abnormal resting‐state functional connectivity in posterior cingulate cortex of Parkinson's disease with mild cognitive impairment and dementia
Zhan, Z., Lin, L., Yu, E., Xin, J., Lin, L., Lin, H., Ye, Q., Chen, X., & Pan, X. (2018) · CNS Neuroscience & Therapeutics · doi:10.1111/cns.12838 · Cited by 66
Transcranial direct current stimulation enhances theory of mind in Parkinson’s disease patients with mild cognitive impairment: a randomized, double-blind, sham-controlled study
Adenzato, M., Manenti, R., Enrici, I., Gobbi, E., Brambilla, M., Alberici, A., Cotelli, M. S., Padovani, A., Borroni, B., & Cotelli, M. (2019) · Translational Neurodegeneration · doi:10.1186/s40035-018-0141-9 · Cited by 67
Hallucinations, Dreaming, and Frequent Dozing in Parkinson Disease: Impact of Right-hemisphere Neural Networks
Stavitsky, K., McNamara, P., Durso, R., Harris, E., Auerbach, S. H., & Cronin‐Golomb, A. (2008) · Cognitive and Behavioral Neurology · doi:10.1097/wnn.0b013e318185e698 · Cited by 66
The Gut Metabolite Trimethylamine N‐oxide Is Associated With Parkinson's Disease Severity and Progression
Chen, S., Kuo, C., Kuo, H., Chen, C., Wu, W., Liou, J., Wu, M., & Lin, C. (2020) · Movement Disorders · doi:10.1002/mds.28246 · Cited by 65
Genetic evaluation of dementia with Lewy bodies implicates distinct disease subgroups
Kaivola, K., Shah, Z., Chia, R., International LBD Genomics Consortium, Black, S. E., Gan-Or, Z., Keith, J., Masellis, M., Rogaeva, E., Brice, A., et al. (2022) · Brain · doi:10.1093/brain/awab402 · Cited by 65
Self-citation
Parkinson’s disease clinical milestones and mortality
González, M. C., Dalen, I., Maple‐Grødem, J., Tysnes, O., & Alves, G. W. (2022) · npj Parkinson s Disease · doi:10.1038/s41531-022-00320-z · Cited by 65
Olfactory Dysfunction and Dementia in Parkinson's Disease
Takeda, A., Baba, T., Kikuchi, A., Hasegawa, T., Sugeno, N., Konno, M., Miura, E., & Mori, E. (2014) · Journal of Parkinson s Disease · doi:10.3233/jpd-130277 · Cited by 65
CSF proteins and resting-state functional connectivity in Parkinson disease
Campbell, M. C., Koller, J. M., Snyder, A. Z., Buddhala, C., Kotzbauer, P. T., & Perlmutter, J. S. (2015) · Neurology · doi:10.1212/wnl.0000000000001681 · Cited by 65
Cerebral microbleeds in patients with Parkinson’s disease
Ham, J. H., Yi, H., Sunwoo, M. K., Hong, J. Y., Sohn, Y. H., & Lee, P. H. (2014) · Journal of Neurology · doi:10.1007/s00415-014-7403-y · Cited by 65
The Reliability and Validity of the Mini-Mental State Examination in the Elderly Croatian Population
Boban, M., Malojčić, B., Mimica, N., Vuković, S., Zrilić, I., Hof, P. R., & Šimic, G. (2012) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000339596 · Cited by 65
Marked N-acetylaspartate and choline metabolite changes in Parkinson's disease patients with mild cognitive impairment
Nie, K., Zhang, Y., Huang, B., Wang, L., Zhao, J., Huang, Z., Gan, R., & Wang, L. (2012) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2012.11.012 · Cited by 65
Apathy and impulse control disorders in Parkinson’s disease: A direct comparison
Leroi, I., Andrews, M., McDonald, K. R., Harbishettar, V., Elliott, R., Byrne, E. J., & Burns, A. S. (2011) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2011.10.005 · Cited by 65
Clinical validation of movement disorder society–recommended diagnostic criteria for Parkinson's disease with dementia
Barton, B. R., Grabli, D., Bernard, B. A., Czernecki, V., Goldman, J. G., Stebbins, G. T., Dubois, B., & Goetz, C. G. (2011) · Movement Disorders · doi:10.1002/mds.24059 · Cited by 65
Self-citation
Association of COMT, MTHFR, and SLC19A1(RFC-1) polymorphisms with homocysteine blood levels and cognitive impairment in Parkinson’s disease
Białecka, M. A., Kurzawski, M., Roszmann, A., Robowski, P., Sitek, E. J., Honczarenko, K., Gorzkowska, A., Budrewicz, S. P., Mak, M., Jarosz, M., et al. (2012) · Pharmacogenetics and Genomics · doi:10.1097/fpc.0b013e32835693f7 · Cited by 71
Development of assessment toolkits for improving the diagnosis of the Lewy body dementias: feasibility study within the DIAMOND Lewy study
Thomas, A. J., Taylor, J., McKeith, I. G., Bamford, C., Burn, D. J., Allan, L. M., & O'Brien, J. T. (2016) · International Journal of Geriatric Psychiatry · doi:10.1002/gps.4609 · Cited by 67
Self-citation
Increased weighting on prior knowledge in Lewy body-associated visual hallucinations
Zarkali, A., Adams, R. A., Psarras, S., Leyland, L., Rees, G. E., & Weil, R. S. (2019) · Brain Communications · doi:10.1093/braincomms/fcz007 · Cited by 65
The Prevalence and Subtypes of Young Onset Dementia in Central Norway: A Population-Based Study
Kvello-Alme, M., Bråthen, G., White, L. R., & Sando, S. B. (2019) · Journal of Alzheimer s Disease · doi:10.3233/jad-181223 · Cited by 71
Altered putamen and cerebellum connectivity among different subtypes of Parkinson's disease
Shen, B., Pan, Y., Jiang, X., Wu, Z., Zhu, J., Dong, J., Zhang, W., Xu, P., Dai, Y., Gao, Y., et al. (2019) · CNS Neuroscience & Therapeutics · doi:10.1111/cns.13259 · Cited by 64
Implication of EEG theta/alpha and theta/beta ratio in Alzheimer’s and Lewy body disease
Baik, K., Jung, J. H., Jeong, S. H., Chung, S. J., Yoo, H. S., Lee, P. H., Sohn, Y. H., Kang, S. W., & Ye, B. S. (2022) · Scientific Reports · doi:10.1038/s41598-022-21951-5 · Cited by 64
The source of the memory impairment in Parkinson's disease: Acquisition versus retrieval
Chiaravalloti, N. D., Ibarretxe‐Bilbao, N., DeLuca, J., Rusu, O., Peña, J., García‐Gorostiaga, I., & Ojeda, N. (2014) · Movement Disorders · doi:10.1002/mds.25842 · Cited by 66
Motor Phenotype of LRRK2 G2019S Carriers in Early-Onset Parkinson Disease
Alcalay, R. N., Mejia‐Santana, H., Tang, M. X., Rosado, L., Verbitsky, M., Kisselev, S., Ross, B. M., Louis, E. D., Comella, C. L., Colcher, A., et al. (2009) · Archives of Neurology · doi:10.1001/archneurol.2009.267 · Cited by 64
Ventricular dilatation and brain atrophy in patients with Parkinson's disease with incipient dementia
Camicioli, R. M., Sabino, J., Gee, M., Bouchard, T. P., Fisher, N., Hanstock, C. C., Emery, D. J., & Martin, W. R. W. (2011) · Movement Disorders · doi:10.1002/mds.23700 · Cited by 65
Dementia associated with Parkinson’s disease: Applying the Movement Disorder Society Task Force criteria
Martínez‐Martín, P., Falup‐Pecurariu, C., Rodríguez‐Blázquez, C., Serrano‐Dueñas, M., Artal, F. J. C., Rojo-Abuín, J. M., & Aarsland, D. (2011) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2011.05.017 · Cited by 64
Self-citation
Using virtual reality to explore the role of conflict resolution and environmental salience in Freezing of Gait in Parkinson's disease
Matar, E., Shine, J. M., Naismith, S. L., & Lewis, S. J. G. (2013) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2013.06.002 · Cited by 64
Dissociations among daytime sleepiness, nighttime sleep, and cognitive status in Parkinson's disease
Goldman, J. G., Ghode, R. A., Ouyang, B., Bernard, B. A., Goetz, C. G., & Stebbins, G. T. (2013) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2013.05.006 · Cited by 64
Self-citation
Cerebrospinal fluid biomarkers of neuropathologically diagnosed Parkinson’s disease subjects
Maarouf, C. L., Beach, T. G., Adler, C. H., Shill, H. A., Sabbagh, M. N., WU, T. L., Walker, D. G., Kokjohn, T. A., Roher, A. E., & Arizona PD Consortium (2012) · Neurological Research · doi:10.1179/1743132812y.0000000063 · Cited by 66
A double-blind comparison of galantamine hydrobromide ER and placebo in Parkinson disease
Grace, J., Amick, M. M., & Friedman, J. H. (2008) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp.2008.144048 · Cited by 64
Cognitive Decline and Dementia Risk in Older Adults With Psychotic Symptoms: A Prospective Cohort Study
Köhler, S., Allardyce, J., Verhey, F. R. J., McKeith, I. G., Matthews, F. E., Brayne, C., & Savva, G. M. (2013) · American Journal of Geriatric Psychiatry · doi:10.1016/j.jagp.2012.10.010 · Cited by 64
Self-citation
Target-Specific PET Probes for Neurodegenerative Disorders Related to Dementia
Kadir, A., & Nordberg, A. K. (2010) · Journal of Nuclear Medicine · doi:10.2967/jnumed.110.077164 · Cited by 64
Speech prosody impairment predicts cognitive decline in Parkinson’s disease
Rektorová, I., Mekyska, J., Janoušová, E., Košťálová, M., Eliasova, I., Mračková, M., Beránková, D., Nečasová, T., Smékal, Z., & Mareček, R. (2016) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2016.05.018 · Cited by 64
A qualitative study of female caregiving spouses’ experiences of intimate relationships as cognition declines in Parkinson’s disease
Vatter, S., McDonald, K. R., Stanmore, E., Clare, L., McCormick, S. A., & Leroi, I. (2018) · Age and Ageing · doi:10.1093/ageing/afy049 · Cited by 64
Subjective cognitive decline and progression to dementia in Parkinson’s disease: a long-term follow-up study
Hernández, I. G., Nieto, A., Lorenzo, J. N., & Barroso, J. (2019) · Journal of Neurology · doi:10.1007/s00415-019-09197-0 · Cited by 64
Hippocampal CA2 Lewy pathology is associated with cholinergic degeneration in Parkinson’s disease with cognitive decline
Liu, A. K. L., Chau, T. W., Lim, E., Ahmed, I., Chang, R. C., Kalaitzakis, M. E., Graeber, M. B., Gentleman, S., & Pearce, R. K. B. (2019) · Acta Neuropathologica Communications · doi:10.1186/s40478-019-0717-3 · Cited by 64
Associations between Plasma Ceramides and Cognitive and Neuropsychiatric Manifestations in Parkinson’s Disease Dementia
Xing, Y., Tang, Y., Zhao, L., Wang, Q., Qin, W., Ji, X., Zhang, J., & Jia, J. (2016) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2016.09.028 · Cited by 63
Longitudinal decline in speech production in Parkinson's disease spectrum disorders
Ash, S., Jester, C., York, C., Kofman, O., Langey, R., Halpin, A., Firn, K., Perez, S. D., Chahine, L. M., Spindler, M., et al. (2017) · Brain and Language · doi:10.1016/j.bandl.2017.05.001 · Cited by 63
Cholinesterase inhibitors and memantine for the treatment of Alzheimer and non-Alzheimer dementias
Balázs, N., Bereczki, D., & Kovács, T. (2021) · Ideggyógyászati Szemle · doi:10.18071/isz.74.0379 · Cited by 65
Olfactory swab sampling optimization for α-synuclein aggregate detection in patients with Parkinson’s disease
Bongianni, M., Catalan, M., Perra, D., Fontana, E., Janes, F., Bertolotti, C., Sacchetto, L., Capaldi, S., Tagliapietra, M., Polverino, P., et al. (2022) · Translational Neurodegeneration · doi:10.1186/s40035-022-00311-3 · Cited by 63
Pathobiology of Cognitive Impairment in Parkinson Disease: Challenges and Outlooks
Jellinger, K. A. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms25010498 · Cited by 73
Mild cognitive impairment in patients with Parkinson's disease is associated with increased cortical degeneration
Hanganu, A., Bedetti, C., Jubault, T., Gagnon, J., Mejia‐Constain, B., Degroot, C., Lafontaine, A., Chouinard, S., & Monchi, O. (2013) · Movement Disorders · doi:10.1002/mds.25541 · Cited by 63
Evaluation of mild cognitive impairment subtypes in Parkinson's disease
Cholerton, B., Zabetian, C. P., Wan, J. Y., Montine, T. J., Quinn, J. F., Mata, I. F., Chung, K. A., Peterson, A. L., Espay, A. J., Revilla, F. J., et al. (2014) · Movement Disorders · doi:10.1002/mds.25875 · Cited by 63
Long-Term Mortality in a Cohort of Home-Dwelling Elderly with Mild Alzheimer's Disease and Lewy Body Dementia
Oesterhus, R., Soennesyn, H., Rongve, A., Ballard, C. G., Aarsland, D., & Vossius, C. (2014) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000358051 · Cited by 63
Self-citation
Biomarkers for Parkison's disease: Tools to assess Parkinson's disease onset and progression
MAREK, K. L., Jennings, D. L., Tamagnan, G. D., & Seibyl, J. P. (2009) · Annals of Neurology · doi:10.1002/ana.21602 · Cited by 64
Mapping track density changes in nigrostriatal and extranigral pathways in Parkinson's disease
Ziegler, E., Rouillard, M., André, E., Coolen, T., Stender, J., Balteau, E., Phillips, C. L. M., & Garraux, G. (2014) · NeuroImage · doi:10.1016/j.neuroimage.2014.06.033 · Cited by 62
Dementia with Lewy Bodies and Parkinson Disease Dementia: It is the Same Disease!
Friedman, J. H. (2017) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2017.07.013 · Cited by 63
Electroencephalographic markers in dementia
Malek, N., Baker, M. R., Mann, C., & Greene, J. (2016) · Acta Neurologica Scandinavica · doi:10.1111/ane.12638 · Cited by 62
Clinical diagnosis of Lewy body dementia
Surendranathan, A., Kane, J. P. M., Bentley, A., Barker, S. A. H., Taylor, J., Thomas, A. J., Allan, L. M., McNally, R., James, P. W., McKeith, I. G., et al. (2020) · BJPsych Open · doi:10.1192/bjo.2020.44 · Cited by 62
Self-citation
Enrichment of extracellular vesicles using Mag-Net for the analysis of the plasma proteome
Wu, C. C., Tsantilas, K. A., Park, J., Plubell, D. L., Sanders, J. A., Naicker, P., Govender, I. S., Buthelezi, S. G., Stoychev, S., Jordaan, J., et al. (2025) · Nature Communications · doi:10.1038/s41467-025-60595-7 · Cited by 121
Subjective memory complaints, depressive symptoms and cognition in Parkinson's disease patients
Lehrner, J. P., Moser, D., Klug, S., Gleiß, A., Auff, E., Pirker, W., & Pußwald, G. (2014) · European Journal of Neurology · doi:10.1111/ene.12470 · Cited by 65
Cognition and driving in older persons
Wagner, J., & Nef, T. (2011) · Swiss Medical Weekly · doi:10.4414/smw.2011.13136 · Cited by 62
Cognitive Rehabilitation for Executive Dysfunction in Parkinson's Disease: Application and Current Directions
Calleo, J., Burrows, C., Levin, H. S., Marsh, L., Lai, E. C., & York, M. K. (2011) · Parkinson s Disease · doi:10.1155/2012/512892 · Cited by 62
Development and assessment of sensitive immuno‐ PCR assays for the quantification of cerebrospinal fluid three‐ and four‐repeat tau isoforms in tauopathies
Luk, C. Y., Compta, Y., Magdalinou, N. K., Martı́, M. J., Hondhamuni, G., Zetterberg, H., Blennow, K., Constantinescu, R., Pijnenburg, Y. A. L., Mollenhauer, B., et al. (2012) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2012.07911.x · Cited by 65
Self-citation
Hippocampal CA1 subfield predicts episodic memory impairment in Parkinson's disease
La, C., Linortner, P., Bernstein, J. D., Cruadhlaoich, M. A. I. U., Fenesy, M. C., Deutsch, G. K., Rutt, B. K., Tian, L., Wagner, A. D., Zeineh, M., et al. (2019) · NeuroImage Clinical · doi:10.1016/j.nicl.2019.101824 · Cited by 62
Parkinsonism and Related Disorders
Slow, E., & Lang, A. E. (2019) · DeckerMed Transitional Year Weekly Curriculum™ · doi:10.2310/tywc.1178 · Cited by 62
Mild cognitive impairment in Parkinson’s disease is associated with decreased P300 amplitude and reduced putamen volume
Gündüz, D. H., Emek‐Savaş, D. D., Çavuşoğlu, B., Çolakoğlu, B. D., Ada, E., & Yener, G. (2019) · Clinical Neurophysiology · doi:10.1016/j.clinph.2019.04.314 · Cited by 61
Plasma NfL, clinical subtypes and motor progression in Parkinson's disease
Pilotto, A., Imarisio, A., Conforti, F., Scalvini, A., Masciocchi, S., Nocivelli, S., Turrone, R., Gipponi, S., Cottini, E., Borroni, B., et al. (2021) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2021.04.016 · Cited by 61
Hyperhomocysteinemia in levodopa‐treated patients with Parkinson's disease dementia
Zoccolella, S., Dell’Aquila, C., Abruzzese, G., Antonini, A., Bonuccelli, U., Canesi, M., Cristina, S., Marchese, R., Pacchetti, C., Zagaglia, R., et al. (2009) · Movement Disorders · doi:10.1002/mds.22511 · Cited by 65
Differential spectral quantitative electroencephalography patterns between control and Parkinson's disease cohorts
Caviness, J. N., Utianski, R. L., Hentz, J. G., Beach, T. G., Dugger, B. N., Shill, H. A., Driver‐Dunckley, E. D., Sabbagh, M. N., Mehta, S. H., & Adler, C. H. (2015) · European Journal of Neurology · doi:10.1111/ene.12878 · Cited by 61
Neuroimaging correlates of cognitive impairment and dementia in Parkinson's disease
Mak, E., Su, L., Williams, G. B., & O'Brien, J. T. (2015) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2015.05.013 · Cited by 61

Authors: Emre, M., Aarsland, D., Brown, R., Burn, D. J., Duyckaerts, C., Mizuno, Y., Broe, G. A., Cummings, J., Dickson, D. W., Gauthier, S., Goldman, J., Goetz, C., Korczyn, A., Lees, A., Levy, R., Litvan, I., McKeith, I., Olanow, W., Poewe, W., Quinn, N., Sampaio, C., Tolosa, E., & Dubois, B.
Affiliations: Istanbul University (TR)
Stavanger University Hospital (NO)
King's College London (GB)
Newcastle University (GB)
Inserm (FR)
Juntendo University (JP)
UNSW Sydney (AU)
University of California, Los Angeles (US)
Mayo Clinic (US)
McGill University Research Centre for Studies in Aging (CA)
Rush University Medical Center (US)
Tel Aviv University (IL)
National Hospital for Neurology and Neurosurgery (GB)
University of Louisville (US)
Newcastle upon Tyne Hospital (GB)
Icahn School of Medicine at Mount Sinai (US)
Innsbruck Medical University (AT)
University of Lisbon (PT)
Hospital Clínic de Barcelona (ES)
Corresponding author: Emre, Murat
ORCID: Aarsland, Dag
Brown, Richard
Burn, David J.
Duyckaerts, Charles
Cummings, Jeffrey
Dickson, Dennis W.
Gauthier, Serge
Goldman, Jennifer
Goetz, Christopher
Korczyn, Amos
Lees, Andrew
Litvan, Irene
McKeith, Ian
Poewe, Werner
Quinn, Niall
Tolosa, Eduardo
Dubois, Bruno
Venue: Movement Disorders
Publisher: Wiley
Published: 2007-05-31
Volume: 22
Issue: 12
Pages: 1689-1707
ISSN: 0885-3185 (ISSN-L)
1531-8257
DOI: 10.1002/mds.21507
OpenAlex: W2166609052
Cited by: 3,027
References: 187
Citations by year: 2026: 141 · 2025: 203 · 2024: 192 · 2023: 174 · 2022: 253 · 2021: 215 · 2020: 202 · 2019: 189 · 2018: 173 · 2017: 153 · 2016: 177 · 2015: 151 · 2014: 161 · 2013: 157 · 2012: 137
FWCI: 8.85
Type: journal article
Language: en
Open access: green
doi.org
Licence: onlinelibrary.wiley.com/termsAndConditions#vor (vor)
Locations: Movement Disorders (publishedVersion)
PubMed (publishedVersion)
UCL Discovery (University College London) (submittedVersion)
Research Portal (King's College London) (submittedVersion)
Newcastle University ePrints (Newcastle Univesity)
Funders: Medical Research Council (G0400074)
National Institute on Aging (R01AG024040)
Topics: Health Sciences › Medicine › Clinical Neurology › Parkinson's Disease Mechanisms and Treatments
Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
Health Sciences › Medicine › Clinical Neurology › Deep Brain Stimulation and Movement Disorders
Keywords: Parkinson's disease dementia, clinical criteria, Lewy bodies, dementia prevalence, executive dysfunction, memory impairment, hallucinations, apathy, behavioral symptoms
MeSH terms: Dementia, Diagnosis, Differential, Humans, Neuropsychological Tests, Parkinson Disease, Severity of Illness Index, Task Performance and Analysis

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Clinical diagnostic criteria for dementia associated with Parkinson’s disease

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks